NZ243627A - 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors - Google Patents

3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors

Info

Publication number
NZ243627A
NZ243627A NZ243627A NZ24362792A NZ243627A NZ 243627 A NZ243627 A NZ 243627A NZ 243627 A NZ243627 A NZ 243627A NZ 24362792 A NZ24362792 A NZ 24362792A NZ 243627 A NZ243627 A NZ 243627A
Authority
NZ
New Zealand
Prior art keywords
deoxy
pharmaceutical compositions
intermediate precursors
mannosamine derivatives
mannosamine
Prior art date
Application number
NZ243627A
Other languages
English (en)
Inventor
Nicola Mongelli
Alberto Bargiotti
Nuccia Oneto
Cristina Geroni
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NZ243627A publication Critical patent/NZ243627A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004Monosaccharides having only carbon, hydrogen and oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/04Antineoplastic agents specific for metastasis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/02Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H5/00Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium
    • C07H5/04Compounds containing saccharide radicals in which the hetero bonds to oxygen have been replaced by the same number of hetero bonds to halogen, nitrogen, sulfur, selenium, or tellurium to nitrogen
    • C07H5/06Aminosugars
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • C07H7/02Acyclic radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NZ243627A 1991-08-06 1992-07-20 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors NZ243627A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919116896A GB9116896D0 (en) 1991-08-06 1991-08-06 3-deoxymannosamine derivatives and process for their preparation

Publications (1)

Publication Number Publication Date
NZ243627A true NZ243627A (en) 1994-04-27

Family

ID=10699545

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ243627A NZ243627A (en) 1991-08-06 1992-07-20 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors

Country Status (16)

Country Link
US (1) US5332756A (enExample)
EP (1) EP0527042A2 (enExample)
JP (1) JPH05208988A (enExample)
KR (1) KR930004325A (enExample)
AU (1) AU646173B2 (enExample)
CA (1) CA2075336A1 (enExample)
FI (1) FI923498L (enExample)
GB (1) GB9116896D0 (enExample)
HU (1) HU213208B (enExample)
IL (1) IL102500A (enExample)
MX (1) MX9204395A (enExample)
MY (1) MY108749A (enExample)
NZ (1) NZ243627A (enExample)
RU (1) RU2099333C1 (enExample)
TW (1) TW248564B (enExample)
ZA (1) ZA925871B (enExample)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9216962D0 (en) * 1992-08-11 1992-09-23 Erba Carlo Spa Therapeutically active naphthalenesulfonic-pyrrolecarboxamido derivatives
GB9304589D0 (en) * 1993-03-05 1993-04-21 Erba Carlo Spa Biologically active ureido derivatives useful as antimetastic agents
FR2723947B1 (fr) * 1994-08-31 1996-09-27 Adir Nouveaux composes tetrahydropyraniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
RU2266734C2 (ru) * 1999-05-13 2005-12-27 Фарма Мар, С.А. Композиции и применение ет743 для лечения злокачественных опухолей
WO2005115408A1 (ja) * 2004-05-26 2005-12-08 National University Corporation Kagawa University 血管内皮細胞の増殖抑制・管腔形成阻害方法
US8148335B2 (en) 2004-06-23 2012-04-03 Children's Hospital & Research Center Oakland De-N-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy
AU2005258301A1 (en) * 2004-06-23 2006-01-05 Children's Hospital & Research Center At Oakland Polysaccharide derivatives and uses in induction of an immune response
CA2644917A1 (en) * 2006-03-15 2007-09-20 Trustees Of Tufts College Fluorinated carbohydrates and their use in tumor visualization, tissue engineering, and cancer chemotherapy
KR100780868B1 (ko) 2006-07-10 2007-11-30 부경대학교 산학협력단 항암효과를 나타내는 4급 아미노 글루코사민 화합물
US8999954B2 (en) * 2007-07-03 2015-04-07 Childern's Hospital & Research Center at Oakland Inhibitors of polysialic acid de-N-acetylase and methods for using the same
EP2173759A4 (en) 2007-07-03 2014-01-29 Childrens Hosp & Res Ct Oak OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE
CA2692417C (en) 2007-07-03 2017-03-21 Children's Hospital & Research Center At Oakland Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
FR2930943B1 (fr) * 2008-05-07 2011-03-18 Centre Nat Rech Scient Nouvelles utilisations de derives de d-mannopyranose inhibiteurs de l'angiogenese

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4216208A (en) * 1978-07-31 1980-08-05 Proter S.P.A. N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
DE3906174A1 (de) * 1989-02-28 1990-08-30 Forschungszentrum Juelich Gmbh Verfahren zur herstellung von d-mannosaminderivaten

Also Published As

Publication number Publication date
ZA925871B (en) 1993-04-28
HU213208B (en) 1997-03-28
TW248564B (enExample) 1995-06-01
HU9202329D0 (en) 1992-10-28
MY108749A (en) 1996-11-30
FI923498A7 (fi) 1993-02-07
KR930004325A (ko) 1993-03-22
EP0527042A2 (en) 1993-02-10
FI923498A0 (fi) 1992-08-03
EP0527042A3 (enExample) 1994-01-05
GB9116896D0 (en) 1991-09-18
MX9204395A (es) 1993-02-01
AU646173B2 (en) 1994-02-10
JPH05208988A (ja) 1993-08-20
AU2037492A (en) 1993-02-11
FI923498L (fi) 1993-02-07
US5332756A (en) 1994-07-26
IL102500A (en) 1996-01-19
IL102500A0 (en) 1993-01-14
CA2075336A1 (en) 1993-02-07
HUT62593A (en) 1993-05-28
RU2099333C1 (ru) 1997-12-20

Similar Documents

Publication Publication Date Title
NZ244766A (en) Bi-aromatic compounds and pharmaceutical compositions
NZ238545A (en) Dialkoxy-pyridinyl-benzimidazole derivatives; preparation and pharmaceutical compositions thereof
HU9303143D0 (en) Pharmaceutical compositions
ZA922834B (en) Pharmaceutical compositions
GB9108080D0 (en) Pharmaceutical composition
AP9200356A0 (en) Pharmaceutical composition
NZ243627A (en) 3-deoxy-mannosamine derivatives and pharmaceutical compositions thereof; intermediate precursors
GB9100465D0 (en) Pharmaceutical compositions
IL102116A (en) Hetaryloxy-beta-carboline derivatives processes for the preparation thereof and pharmaceutical compositions containing the same
NZ239483A (en) Phosphonopyrrolidine or -piperidine derivatives and pharmaceutical compositions
GB9214757D0 (en) Pharmaceutical compositions
NZ241331A (en) 3-phenyl-2-alkenamide derivatives and pharmaceutical compositions thereof
GB9120672D0 (en) Pharmaceutical compositions
GB9111477D0 (en) Pharmaceutical composition
GB2252497B (en) Pharmaceutical composition
GB9221212D0 (en) Pharmaceutical compositions
NZ248197A (en) 21-chloro-pregnane derivatives, preparation, use, and pharmaceutical compositions thereof
GB9200414D0 (en) Pharmaceutical compositions
GB9110884D0 (en) Pharmaceutical compositions
GB9107278D0 (en) Pharmaceutical compositions
GB9123423D0 (en) Pharmaceutical compositions
GB9121989D0 (en) Pharmaceutical compositions
GB9121291D0 (en) Pharmaceutical compositions
GB9119048D0 (en) Pharmaceutical compositions
GB9118481D0 (en) Pharmaceutical compositions